Related Experiment Video
Updated: Jan 27, 2026

Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR RS-PCR
Published on: November 4, 2016
High-Throughput Screening for Inhibitors of Wall Teichoic Acid Biosynthesis in Staphylococcus aureus
Omar M El-Halfawy1,2,3, Eric D Brown4,5
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Abstract:
The world is heading toward a dangerous post-antibiotic era where antibiotics fail to treat infections. Staphylococcus aureus is the leading cause of healthcare-associated infections worldwide, and an ever-increasing percentage of them are methicillin-resistant (MRSA). New strategies are urgently needed to combat this pathogen. Wall teichoic acids (WTA) in S. aureus are polyribitol phosphate polymers that play important roles in virulence and resistance to β-lactam antibiotics. Here, we describe a high-throughput whole-cell screening platform for inhibitors targeting WTA biosynthesis. This platform takes advantage of the unique dispensability patterns of genes encoding WTA biosynthesis. We further describe follow-up dose-response assays to identify WTA inhibitors among the primary bioactives. WTA inhibitors offer an exciting opportunity for the development of novel antibacterial leads of unique mechanism in the fight against drug-resistant staphylococcal infections.
Insights
New screening methods identify novel inhibitors of wall teichoic acid (WTA) biosynthesis in Staphylococcus aureus. These WTA inhibitors offer a promising strategy against antibiotic-resistant bacteria like MRSA.
Area of Science:
- Microbiology
- Drug Discovery
- Infectious Diseases
Background:
- The rise of antibiotic resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), necessitates novel therapeutic strategies.
- Wall teichoic acids (WTA) are crucial for S. aureus virulence and resistance to beta-lactam antibiotics.
- Targeting WTA biosynthesis presents a promising avenue for developing new antibacterial agents.
Purpose of the Study:
- To develop and implement a high-throughput screening platform for identifying inhibitors of WTA biosynthesis in S. aureus.
- To validate the identified compounds through dose-response assays.
Main Methods:
- A whole-cell screening platform was designed utilizing the unique dispensability patterns of genes involved in WTA biosynthesis.
- Primary bioactive hits were subjected to follow-up dose-response assays to determine their inhibitory concentrations.
Main Results:
- The screening platform successfully identified compounds that inhibit WTA biosynthesis.
- Follow-up assays confirmed the efficacy of selected WTA inhibitors.
Conclusions:
- The developed screening platform is effective for discovering novel inhibitors of WTA biosynthesis.
- WTA inhibitors represent a promising class of compounds for combating drug-resistant staphylococcal infections.
- This approach offers a new mechanism to fight against MRSA infections.
More Related Videos
Related Concept Videos
Biosynthesis of Nucleic Acids
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Biosynthesis of Lipids
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

